Sequential provocation of Ekbom’s syndrome and acute mania following AstraZeneca COVID-19 vaccination

ChAdOx1 nCoV-19 vaccine (so called AZ vaccine), is widely used to prevent the SARS-CoV-2 pandemic and shows powerful effectiveness to deter community transmission. There are common immunogenicity-related side effects such as fever, myalgia, lethargy, and headache; however, rare report on the neurops...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Fang-Yu, Chen, Po-An, Siao, Wen-Huei, Chen, Yi-Chyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039778/
https://www.ncbi.nlm.nih.gov/pubmed/37012199
http://dx.doi.org/10.1016/j.ajp.2023.103569
Descripción
Sumario:ChAdOx1 nCoV-19 vaccine (so called AZ vaccine), is widely used to prevent the SARS-CoV-2 pandemic and shows powerful effectiveness to deter community transmission. There are common immunogenicity-related side effects such as fever, myalgia, lethargy, and headache; however, rare report on the neuropsychiatric problems (Ramasamy et al., 2021). In Taiwan, more than 15,200,000 doses of AZ vaccine were injected by the end of 2022. Here we presented a unique case with separated episode of Ekbom’s syndrome, also called delusion of parasitosis, and mania following successive AZ vaccination in three-month interval.

Ejemplares similares